Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1. 2004

Joseph H Chan, and George A Freeman, and Jeffrey H Tidwell, and Karen R Romines, and Lee T Schaller, and Jill R Cowan, and Steve S Gonzales, and Gina S Lowell, and C W Andrews, and David J Reynolds, and Marty St Clair, and Richard J Hazen, and Rob G Ferris, and Katrina L Creech, and Grace B Roberts, and Steven A Short, and Kurt Weaver, and George W Koszalka, and Lawrence R Boone
GlaxoSmithKline Inc., 5 Moore Drive, Research Triangle Park, North Carolina 27709, USA. joe.h.chan@gsk.com

GW4511, GW4751, and GW3011 showed IC50 values < or =2 nM against wild type HIV-1 and <10 nM against 16 mutants. They were particularly potent against NNRTI-resistant viruses containing Y181C-, K103N-, and K103N-based double mutations, which account for a significant proportion of the clinical failure of the three currently marketed NNRTIs. The antiviral data together with the favorable pharmacokinetic data of GW4511 suggested that these benzophenones possess attributes of a new NNRTI drug candidate.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001577 Benzophenones Derivatives of benzophenone (with the structural formula phenyl-(C
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

Joseph H Chan, and George A Freeman, and Jeffrey H Tidwell, and Karen R Romines, and Lee T Schaller, and Jill R Cowan, and Steve S Gonzales, and Gina S Lowell, and C W Andrews, and David J Reynolds, and Marty St Clair, and Richard J Hazen, and Rob G Ferris, and Katrina L Creech, and Grace B Roberts, and Steven A Short, and Kurt Weaver, and George W Koszalka, and Lawrence R Boone
November 2016, Yao xue xue bao = Acta pharmaceutica Sinica,
Joseph H Chan, and George A Freeman, and Jeffrey H Tidwell, and Karen R Romines, and Lee T Schaller, and Jill R Cowan, and Steve S Gonzales, and Gina S Lowell, and C W Andrews, and David J Reynolds, and Marty St Clair, and Richard J Hazen, and Rob G Ferris, and Katrina L Creech, and Grace B Roberts, and Steven A Short, and Kurt Weaver, and George W Koszalka, and Lawrence R Boone
February 2017, Bioorganic chemistry,
Joseph H Chan, and George A Freeman, and Jeffrey H Tidwell, and Karen R Romines, and Lee T Schaller, and Jill R Cowan, and Steve S Gonzales, and Gina S Lowell, and C W Andrews, and David J Reynolds, and Marty St Clair, and Richard J Hazen, and Rob G Ferris, and Katrina L Creech, and Grace B Roberts, and Steven A Short, and Kurt Weaver, and George W Koszalka, and Lawrence R Boone
August 2012, ACS medicinal chemistry letters,
Joseph H Chan, and George A Freeman, and Jeffrey H Tidwell, and Karen R Romines, and Lee T Schaller, and Jill R Cowan, and Steve S Gonzales, and Gina S Lowell, and C W Andrews, and David J Reynolds, and Marty St Clair, and Richard J Hazen, and Rob G Ferris, and Katrina L Creech, and Grace B Roberts, and Steven A Short, and Kurt Weaver, and George W Koszalka, and Lawrence R Boone
September 2009, Bioorganic & medicinal chemistry letters,
Joseph H Chan, and George A Freeman, and Jeffrey H Tidwell, and Karen R Romines, and Lee T Schaller, and Jill R Cowan, and Steve S Gonzales, and Gina S Lowell, and C W Andrews, and David J Reynolds, and Marty St Clair, and Richard J Hazen, and Rob G Ferris, and Katrina L Creech, and Grace B Roberts, and Steven A Short, and Kurt Weaver, and George W Koszalka, and Lawrence R Boone
December 2017, Biochemistry. Biokhimiia,
Joseph H Chan, and George A Freeman, and Jeffrey H Tidwell, and Karen R Romines, and Lee T Schaller, and Jill R Cowan, and Steve S Gonzales, and Gina S Lowell, and C W Andrews, and David J Reynolds, and Marty St Clair, and Richard J Hazen, and Rob G Ferris, and Katrina L Creech, and Grace B Roberts, and Steven A Short, and Kurt Weaver, and George W Koszalka, and Lawrence R Boone
June 2012, ACS medicinal chemistry letters,
Joseph H Chan, and George A Freeman, and Jeffrey H Tidwell, and Karen R Romines, and Lee T Schaller, and Jill R Cowan, and Steve S Gonzales, and Gina S Lowell, and C W Andrews, and David J Reynolds, and Marty St Clair, and Richard J Hazen, and Rob G Ferris, and Katrina L Creech, and Grace B Roberts, and Steven A Short, and Kurt Weaver, and George W Koszalka, and Lawrence R Boone
October 2019, Molecules (Basel, Switzerland),
Joseph H Chan, and George A Freeman, and Jeffrey H Tidwell, and Karen R Romines, and Lee T Schaller, and Jill R Cowan, and Steve S Gonzales, and Gina S Lowell, and C W Andrews, and David J Reynolds, and Marty St Clair, and Richard J Hazen, and Rob G Ferris, and Katrina L Creech, and Grace B Roberts, and Steven A Short, and Kurt Weaver, and George W Koszalka, and Lawrence R Boone
February 2006, Current opinion in investigational drugs (London, England : 2000),
Joseph H Chan, and George A Freeman, and Jeffrey H Tidwell, and Karen R Romines, and Lee T Schaller, and Jill R Cowan, and Steve S Gonzales, and Gina S Lowell, and C W Andrews, and David J Reynolds, and Marty St Clair, and Richard J Hazen, and Rob G Ferris, and Katrina L Creech, and Grace B Roberts, and Steven A Short, and Kurt Weaver, and George W Koszalka, and Lawrence R Boone
December 2013, Future medicinal chemistry,
Joseph H Chan, and George A Freeman, and Jeffrey H Tidwell, and Karen R Romines, and Lee T Schaller, and Jill R Cowan, and Steve S Gonzales, and Gina S Lowell, and C W Andrews, and David J Reynolds, and Marty St Clair, and Richard J Hazen, and Rob G Ferris, and Katrina L Creech, and Grace B Roberts, and Steven A Short, and Kurt Weaver, and George W Koszalka, and Lawrence R Boone
February 2006, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!